Skip to main content

Oluwadamilola Motunrayo Fayanju, MD, MA, MPHS

Associate Professor of Surgery
Associate Professor in Population Health Sciences
Campus Mail: DUMC DUMC 3513, Durham, NC 27710

Dr. Fayanju is an Associate Professor of Surgery and Population Health Sciences in the Duke University School of Medicine, Associate Director for Disparities & Value in Healthcare with Duke Forge (the university’s center for actionable data science: https://forge.duke.edu/oluwadamilola-fayanju-md-ma-mphs), and Director of the Durham VA Breast Clinic.

She received her undergraduate degree in History and Science and an MA in Comparative Literature from Harvard. She received her MD and a master of population health sciences (MPHS) from Washington University in St. Louis, where she also completed her residency in General Surgery. She completed fellowship training in Breast Surgical Oncology at The University of Texas MD Anderson Cancer Center.

Her research, which is supported by an NIH K08 career development award, has 3 areas of focus: (1) addressing disparities in breast cancer presentation, treatment, outcome, and clinical trial participation; (2) improving prognostication and treatment for biologically aggressive variants of breast cancer that are often more common among racial and ethnic minorities; and (3) creating value in oncologic care, especially through the collection and application of patient-reported outcomes (PROs). Her scholarship has been published in a variety of journals including Annals of Surgery, Cancer, and JAMA.

She is active in several national organizations, currently serving on the Board of Directors for the Surgical Outcomes Club and on various committees including the Breast, Cancer Care Delivery, and Health Disparities Committees for the Alliance for Clinical Trials in Oncology; the Patient-reported Outcomes, Patient Safety and Quality, and Publications Committees for the American Society of Breast Surgeons (ASBrS); the Nominating and Program Committees for the Association for Academic Surgery (AAS); the Women in Surgery Committee for the Society of Black Academic Surgeons (SBAS); and the Locoregional and Patient-reported Outcomes Committees for the Translational Breast Cancer Research Consortium (TBCRC).

Education and Training

  • Breast Surgical Oncology Fellow, Surgery, University of Texas MD Anderson Cancer Center, 2015 - 2016
  • General Surgery Resident, Surgery, Washington University School of Medicine, 2007 - 2015
  • M.P.H.S., Washington University School of Medicine, 2011
  • M.D., Washington University School of Medicine, 2007
  • M.A., Harvard University , 2001
  • A.B., Harvard University , 2001

Publications

Rao, Roshni, Lisa Bailey, Tiffany Berry, Robert Buras, Amy Degnim, Oluwadamilola Fayanju, Joshua Froman, et al. “Select choices in benign breast disease.” In Annals of Surgical Oncology, 25:304–5. SPRINGER, 2018.

Scholars@Duke

Plichta, Jennifer Kay, Samantha M. Thomas, Amanda R. Sergesketter, Oluwadamilola Motunrayo Fayanju, Rachel Adams Greenup, Laura Horst Rosenberger, Gretchen Genevieve Kimmick, Terry Hyslop, and Eun-Sil Shelley Hwang. “Restaging de novo metastatic breast cancer to refine prognostic estimates.” In Journal of Clinical Oncology, 36:e13083–e13083. American Society of Clinical Oncology (ASCO), 2018. https://doi.org/10.1200/jco.2018.36.15_suppl.e13083.

Full Text

Tamirisa, Nina Prabha, Hannah Vernia, Samantha M. Thomas, Kelly E. Westbrook, Rachel Adams Greenup, Jennifer Kay Plichta, Laura Horst Rosenberger, Terry Hyslop, Eun-Sil Shelley Hwang, and Oluwadamilola Motunrayo Fayanju. “The impact of chemotherapy sequence on survival in node-positive invasive lobular carcinoma.” In Journal of Clinical Oncology, 36:587–587. American Society of Clinical Oncology (ASCO), 2018. https://doi.org/10.1200/jco.2018.36.15_suppl.587.

Full Text

Landercasper, Jeffrey, Oluwadamilola M. Fayanju, Lisa Bailey, Tiffany S. Berry, Andrew J. Borgert, Robert Buras, Steven L. Chen, et al. “Benchmarking the American Society of Breast Surgeon Member Performance for More Than a Million Quality Measure-Patient Encounters.” Ann Surg Oncol 25, no. 2 (February 2018): 501–11. https://doi.org/10.1245/s10434-017-6257-9.

Full Text

Plichta, J. K., S. M. Thomas, R. A. Greenup, O. M. Fayanju, L. H. Rosenberger, N. Tamirisa, T. Hyslop, and E. S. Hwang. “Clinical and Pathologic Stage Discordance is Associated with Breast Cancer Prognosis.” In Annals of Surgical Oncology, 25:S94–S94. SPRINGER, 2018.

Scholars@Duke

Fayanju, O. M., K. Yenokyan, B. A. Goldstein, I. Stashko, S. Power, and E. S. Hwang. “ 5000 Patient Visits.” In Annals of Surgical Oncology, 25:S54–S54. SPRINGER, 2018.

Scholars@Duke

Thomas, S. M., O. M. Fayanju, J. K. Plichta, L. H. Rosenberger, J. Force, T. Hyslop, E. S. Hwang, and R. A. Greenup. “Treatment Patterns and Outcomes for Breast Cancer with Isolated Supraclavicular Metastases.” In Annals of Surgical Oncology, 25:S26–S26. SPRINGER, 2018.

Scholars@Duke

Fayanju, O. M., A. A. Sahin, and K. K. Hunt. “Noninvasive breast cancer.” In The MD Anderson Surgical Oncology Handbook, Sixth Edition, 1–30, 2018.

Scholars@Duke

Pages